🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
Cytomegalovirus is the most important opportunistic infection after kidney ...
Status
Unknown
Location
Hospital do Rim
Start Date
2015-09
Trial ID
NCT02671318
Treatments Being Tested
This study will evaluate whether conversion from cyclosporine, a calcineuri...
Status
Terminated
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00452361
Solid organ transplantation is the treatment of choice for patients sufferi...
Status
Unknown
Location
Cliniques universitaires Saint-Luc
Start Date
2020-02-10
Trial ID
NCT04360031
Treatments Being Tested
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested
The objective of this extension study is to allow patients being treated wi...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00241059
Treatments Being Tested
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418
This study introduces a new optimization immunosuppressive regimen associat...
Status
Completed
Location
Novartis
Start Date
2005-12
Trial ID
NCT00284934
Treatments Being Tested
The goal of this clinical trial is to learn if patients who have brittle ty...
Status
Enrolling By Invitation
Location
Stanford University
Start Date
2024-04-15
Trial ID
NCT05973734